Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01377649 · ClinicalTrials.gov registry record
Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)
A clinical trial, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- 18
- Enrollment target
NCT01377649: Completed study, sponsored by Oregon Health and Science University.
NCT01377649 is a clinical trial that has completed, run by Oregon Health and Science University. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01377649 has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
Contrast ultrasound is a technique that can quantify blood flow in the tissues of the body by ultrasound detection of microbubble contrast agents that behave in the circulation similar to red blood cells. In this study, the investigators hypothesize that contrast ultrasound of blood flow in the leg (thigh and calf) at rest and during stress produced by medications that mimic exercise (vasodilator stress) can provide information on the location and severity of peripheral vascular disease (blockages of the blood vessels in the leg). The investigators will also determine whether symptom improvement after revascularization (procedures to open up or bypass the blockages) is directly related to the improvement in blood flow.
Primary Outcome
Correlation of skeletal muscle perfusion with symptom status
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2011-07 |
| Est. Completion | 2016-09 |
What the finished NCT01377649 record still lists
NCT01377649 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01377649 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01377649 about?
NCT01377649 is a clinical study titled "Contrast Ultrasound Perfusion Imaging in Peripheral Arterial Disease (PAD)". Contrast ultrasound is a technique that can quantify blood flow in the tissues of the body by ultrasound detection of microbubble contrast agents that behave in the circulation similar to red blood cells. In this study, the investigators hypothesize that contrast ultrasound of blood flow in the leg ...
What is the current status of trial NCT01377649?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2011-07. Estimated completion is 2016-09.
Who is sponsoring clinical trial NCT01377649?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia